Richard Lee Krebs

This inventor holds 14 USPTO granted patents and 1 published patent application, plus 9 CIPO patents and 6 EPO patents. Top assignees: Zoetis Services LLC, Pfizer Corporation, Zoetis LLC. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Lee Krebs. Retrieved from https://idiyas.com/inventor/richard-lee-krebs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 7.6

ph-index = 6

Forward Citations = 93(Granted Patents)

Location History:

Lincoln, NE (US) (2018)
Ashland, NE (US) (2006 - 2024)

Company Filing History:

Years Active: 2006-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12521433 - Novel Adjuvant Compositions (2026-01-13),

2. 12121576 - Oil-based adjuvants (2024-10-22),

3. 11896666 - Adjuvant compositions (2024-02-13),

4. 11701415 - Oil-based adjuvants (2023-07-18),

5. 10953080 - Oil-based adjuvants (2021-03-23),

6. 10940202 - Adjuvant compositions (2021-03-09),

7. 10238736 - Adjuvant compositions (2019-03-26),

8. 10117921 - Oil-based adjuvants (2018-11-06),

9. 9662385 - Adjuvant compositions (2017-05-30),

10. 9289482 - Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins (2016-03-22),

11. 8771727 - Microfluidized oil-in-water emulsions and vaccine compositions (2014-07-08),

12. 8580280 - Adjuvant compositions (2013-11-12),

13. 7736658 - Canine combination vaccines (2010-06-15),

14. 7122191 - Microfluidized oil-in-water emulsions and vaccine compositions (2006-10-17),

Title: Exploring the Inventive World of Richard Lee Krebs

Introduction:

Richard Lee Krebs, a prolific inventor hailing from Ashland, NE, has made significant contributions to the field of adjuvant formulations. With an impressive portfolio of 12 patents to his name, Krebs continues to innovate and push the boundaries of immunogenic and vaccine compositions.

Latest Patents:

1. Adjuvant compositions: Krebs' adjuvant formulations encompass a diverse range of components such as triterpenoids, sterols, and immunomodulators. These formulations are integral in enhancing the efficacy of vaccines and immunogenic compositions, particularly in the treatment of animals.

2. Oil-based adjuvants: In his latest invention, Krebs introduces formulations with immunostimulating oligonucleotides and polycationic carriers in oil emulsions. These formulations play a crucial role in the development of immunogenic compositions and vaccines, as well as in the treatment of animals.

Career Highlights:

Krebs has lent his expertise to esteemed companies such as Zoetis Services LLC and Pfizer Corporation. His innovative mindset and dedication to advancing immunology have left an indelible mark on the industry.

Collaborations:

Throughout his career, Krebs has collaborated with industry peers such as Paul Joseph Dominowski and James Richard Thompson. These partnerships have further enriched his knowledge and propelled his inventive endeavors forward.

Conclusion:

Richard Lee Krebs stands out as a visionary inventor in the realm of adjuvant formulations. His pioneering work has not only revolutionized the way we approach immunogenic compositions but has also paved the way for advancements in animal healthcare. Krebs' relentless pursuit of innovation serves as an inspiration to aspiring inventors and researchers in the field.

Profile summary based on public USPTO records.